BSTZ

I recommend BlackRock Science and Technology Term Trust with a Buy rating for diversified exposure to both public and private AI-driven technology equities. BSTZ's portfolio is concentrated in AI growth themes, including significant positions in Databricks (13.51% of net assets) and Anthropic (4.08%), capturing enterprise AI adoption trends. The fund trades at a -7% discount to NAV, but near-term returns are expected to be driven by asset appreciation rather than NAV convergence.

NEW YORK--(BUSINESS WIRE)---- $BST--BlackRock Science and Technology Trust (NYSE: BST) and BlackRock Science and Technology Term Trust (NYSE: BSTZ) (each, a "Fund" and together, the "Funds") announced today the declaration of special distributions, payable on September 30, 2026 to shareholders of record as of September 15, 2026 (ex-date September 15, 2026). The special distributions reflect substantial realized gains generated by the Funds' strong investment performance, including cumulative fiscal year.

BlackRock Science and Technology Term Trust offers pre-IPO exposure to high-profile tech firms like Anthropic. BSTZ focuses on total return and income, targeting long-term capital appreciation in U.S. and non-U.S. science and technology equities. As a closed-end fund, BSTZ trades at a discount or premium to NAV (currently a discount), thus creating potential for additional returns if the discount narrows.

The BlackRock Science and Technology Term Trust (NYSE:BSTZ) is an unusual tech vehicle: a closed-end fund with a 2031 liquidation date, an expense ratio near 1.4%, and over 30% of its portfolio invested in private, pre-IPO companies.

BlackRock Science & Technology Term Trust (NYSE:BSTZ) is a closed-end fund with a fixed expiration date, a covered call overlay, and more than 30% of its portfolio locked in private, pre-IPO companies that most investors cannot access through a brokerage account.

BlackRock Science & Technology Term Trust (NYSE:BSTZ) is a closed-end fund (CEF) that combines a venture-stage technology portfolio with a covered call writing strategy to deliver monthly income.

BSTZ has dramatically shifted its portfolio, now heavily concentrated in private, illiquid technology and AI investments. BSTZ's private assets, including Anthropic at 15% of holdings, now comprise nearly half the portfolio, heightening liquidity and valuation risks. Distribution and management changes, along with increased private exposure, have altered BSTZ's risk profile and diverged from its original mandate.

BlackRock Science and Technology Term Trust (NYSE:BSTZ) has gained 57.79% over the past year, with shares recently touching $23.92.

There are three stories moving markets right now: